Promising results of new Alzheimers Drug

in Research Updates
July 5th, 2018

Finally some good news about a clinical trial, and even one that Boston University Alzheimer’s Disease Center was a site for!  The BAN2401 study (sponsored by Eisai and Biogen) topline results came out, indicating a significant outcome. This was a Phase 2 study so up next will be Phase 3.

Click here for full Press Release